LCILX
Price
$30.23
Change
-$0.24 (-0.79%)
Updated
Jul 13 closing price
Net Assets
96.85M
VSTSX
Price
$354.42
Change
-$2.83 (-0.79%)
Updated
Jul 13 closing price
Net Assets
2.3T
Interact to see
Advertisement

LCILX vs VSTSX

LCILX vs VSTSX Comparison Chart in %
View a ticker or compare two or three
VS
LCILX vs. VSTSX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LCILX is a Hold and VSTSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSTSX has more cash in the bank: 2.3T vs. LCILX (96.8M). VSTSX pays higher dividends than LCILX: VSTSX (1.07) vs LCILX (0.35). LCILX was incepted earlier than VSTSX: LCILX (11 years) vs VSTSX (10 years). LCILX (0.90) is less costly to investors than VSTSX (0.01). LCILX is a more actively managed with annual turnover of: 44.00 vs. VSTSX (3.00). LCILX has a lower initial minimum investment than VSTSX: LCILX (1000000) vs VSTSX (5000000000). VSTSX annual gain was more profitable for investors over the last year : 21.48 vs. LCILX (12.49). VSTSX return over 5 years is better than : 66.56 vs. LCILX (30.12).
LCILXVSTSXLCILX / VSTSX
Total Expense Ratio0.750.017,500%
Annual Report Gross Expense Ratio0.900.019,000%
Fund Existence11 years10 years-
Gain YTD11.12311.20599%
Front LoadN/AN/A-
Min. Initial Investment100000050000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets96.8M2.3T0%
Annual Yield % from dividends0.351.0732%
Returns for 1 year12.4921.4858%
Returns for 3 years34.3667.0651%
Returns for 5 years30.1266.5645%
Returns for 10 years220.64239.5392%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PWCIX95.22N/A
N/A
Principal Capital Appreciation Inst
PRLAX24.44N/A
N/A
T. Rowe Price Latin America
PACLX37.66N/A
N/A
T. Rowe Price Capital Appreciation Adv
RLIEX20.52N/A
N/A
Lazard International Equity R6
MCYIX16.37-0.51
-3.02%
NYLI Candriam Emerging Markets Eq Cl I